Back to Search Start Over

What Else Can We Use in The Discrimination of Activated MS Plaques in Addition to Diffusion MRI?

Authors :
Karaman A
Source :
The Eurasian journal of medicine [Eurasian J Med] 2020 Feb; Vol. 52 (1), pp. 98-99.
Publication Year :
2020

Abstract

Acute respiratory distress syndrome is characterized by dyspnea at presentation, tachypnea on physical examination, findings of bilateral infiltration in chest radiography, refractory hypoxia, and high mortality. Although the main treatment approach is to address the underlying disease, there are also pharmacological and nonpharmacological options for supportive treatment. There is currently no pharmacological agent with proven efficacy in this syndrome, and many drugs are being studied for this purpose. One of these is the endothelin receptor antagonist bosentan.<br />Competing Interests: Conflict of Interest: The author has no conflicts of interest to declare.<br /> (©Copyright 2020 by the Atatürk University School of Medicine - Available online at www.eurasianjmed.com.)

Details

Language :
English
ISSN :
1308-8734
Volume :
52
Issue :
1
Database :
MEDLINE
Journal :
The Eurasian journal of medicine
Publication Type :
Academic Journal
Accession number :
32158324
Full Text :
https://doi.org/10.5152/eurasianjmed.2020.19238